Mediwound Ltd (MDWD) FinancialsMDWDMediwound Ltd

Evaluating the bottom line, Mediwound Ltd maintains a gross margin of 10.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -305.89%, while the net margin is -239.07%. These profitability ratios, combined with a Return on Equity (ROE) of -55.25%, provide a clear picture of how effectively MDWD converts its operational activities into shareholder value.

In the context of the broader market, MDWD competes directly with industry leaders such as ORMP and OGCP. With a market capitalization of $174.53M, it holds a significant position in the sector. When comparing efficiency, MDWD's gross margin of 10.90% stands against ORMP's N/A and OGCP's N/A. Such benchmarking helps identify whether Mediwound Ltd is trading at a premium or discount relative to its financial performance.

MediWound's revenue for Q2 2026 was $3.1 million, down from $5.7 million in Q2 2025, indicating a reliance on government contracts. The gross margin for Q2 2026 was 10.90%, which is low but reflects the company's ongoing investment in R&D for its product pipeline.